JAHSR 2010 - TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

COMMUNITY HEALTH FUND AS A COMPLEMENTARY FINANCING OPTION IN TANZANIA Presented at CHF Best Practice Workshop: 31 st Jan – 2 nd Feb Golden Tulip.
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Global Alliance for Vaccines and Immunization. WHAT IS GAVI ?
1 European Region Global Alliance for Vaccines & Immunization Overview on the Implementation Of the Introduction of New / Under-used Vaccines.
Pentavalent vaccine Introduction in UIP in India:
Reproductive and Child Health (R&CH) Presented by: Dr. Mariam J. Bakar & Mr. Yusuph Haji.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
TRCS EXPERIENCE ON SOCIAL MOBILIZATION FOR INTEGRATED MEASLES CAMPAIGN OF 2011 TANZANIA RED CROSS SOCIETY MEASLES & RUBELLA INITIATIVE MEETING WASHINGTON.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
THE HEALTH SECTOR COORDINATING STRUCTURES Presentation to the Reproductive Health ICC SWAp Secretariat.
MINISTRY OF COMMUNITY DEVELOPMENT MOTHER AND CHILD HEALTH MRS. ELIKA KAMIJI CHIEF EPI OFFICER IMPLEMENTATION OF GAPPD: ZAMBIAN EXPERIENCE Global Immunization.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Supporting Routine AND Supplementary Immunization Activities in STOP.
21 st May pm WHO conference room Expanded Program on Immunization.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Common recommendations and next steps for improving local delivery of climate finance Bangkok, October 31, 2012.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
UNIVERSITY OF DAR ES SALAAM, TANZANIA ACTIVITIES ON INTERNATIONAL RELATIONS: EXPERIENCE AND CHALLENGES By. H.R.T. Muzale and R. Toba.
Expanded Program of Immunization Dr. Faten M. Rabie.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Report on the Evaluation Function Evaluation Office.
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
February 21, JAS Consultation between the Government of Tanzania and Development Partners February 21, 2006 Courtyard Hotel, Dar es Salaam.
Health Service Delivery Cluster Response to Typhoon Yolanda Center for Health Development- Western Visayas.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Measles elimination Dr. As’ad Ramlawi Palestine..
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
MEASLES AND RUBELLA INITIATIVE Presentation by : Sylvia Khamati. Health Advisor Kenya Red Cross Society “Story from the Field” 15 th September 2015 American.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Global Advocacy Working Group Second report back.
African Centre for Statistics United Nations Economic Commission for Africa Proposed Framework for Monitoring, Evaluation and Reporting Negussie Gorfe.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Situation analysis Puntland State of Somalia Garowe 28th May 2001.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
GHANA HEALTH SERVICE, EASTERN REGION MID-YEAR REVIEW 2014 WAY FORWARD BY RDHS.
FETP PROJECT PRESENTATION Leela K. Zaizay Public Health Training Lead November 2, 2015.
1 EPI services for migrant populations in Tak province.
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Country: Sierra Leone Case: Immunization Legislation Presented By: Hon. A.B.D. Sesay Chairman, Parliamentary Health Committee House of Parliament Sabin.
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Measles.
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Sabin peer review workshop on sustainable immunization financing Abuja, Nigeria April 2016 Country: Uganda Case: Pursuing financial sustainability.
UGANDA: Budgeting, resource tracking and domestic advocacy practices.
Strengthening the 2YL Platform & Men A Introduction Plan in Ghana
iCCM Experience Malawi
CHALLENGES AND PROSPECTS OF IMMUNIZATION IN NIGERIA
The Polio Eradication and Endgame Strategic Plan
<COUNTRY NAME> EPI REVIEW
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Kenya Pediatric Association Conference,
Presentation transcript:

JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam

Outline of presentation EPI performance Major activities done EPI Review findings and recommendation WPV outbreak and response Introduction of new vaccines Measles campaign Way forward

Routine immunization DPT-Heb/Hib3 coverageUn vaccinated children %6%11%15%20%19%

Summary of EPI Surveillance performance AFP SurveillanceMeasles Surveillance

Major activities done 1.EPI Review: 17 th to 28 th May REC approach 3.Supportive supervision in 7 regions 4.Outbreak response of WPV in Kalemie DRC

EPI Review findings: conclusions 1.Proper ICC not in place 2.The strong foundation and visibility of the program has weakened over the years. 3.Efforts to improve performance (REC approach) have demonstrated that coverage can be improved with focused support to districts. 4.Government procures all traditional vaccines and funds for vaccines are protected 5.Inadequate operational funds due decreasing funds allocation to EPI at national level 6.The integration of management of EPI supplies with other medical supplies has weakened the direct oversight of EPI logistics.

EPI Review findings: conclusions 7.The cold storage capacity is inadequate for routine EPI. 8.An improvement in AFP surveillance performance is observed, however active search and measles surveillance performance is inadequate. 9.No refresher training and MLM courses are conducted once in service. 10.There has been sustained commitment of the GoT to maintain a protected budget line for EPI vaccines; however the operational budget is a major constraint.

EPI Review Recommendations: 41 Programme management and coordination: 8 recommendations Financing for immunization: 7 recommendations Logistics, Vaccine Supply and Quality: 8 recommendations Immunization services delivery: 4 recommendations Disease surveillance: 5 recommendations Data management: 9 recommendations

Program Management and Coordination: Recommendation Re-establish the ICC with the recommended chair and membership to strengthen coordination mechanisms of the program with all relevant stakeholders including the private sector Define the link of the ICC with other existing stakeholder coordination structures, such as the Technical SWAp. Institutionalize EPI Technical Working Group to function as the Secretariat of the ICC Re-position EPI as a section within the Directorate of Preventive Services and NOT a sub section within the RCH Section taking into account the increasing scope of the vaccines targeting different age groups beyond infancy

Designate Focal Persons at regional and district level (Immunization and Vaccines Officers) who will be dedicated solely for Immunization and Vaccines activities and given clear ToR to ensure adequate time is allocated for quality immunization services. Revise the immunization schedule for OPV/Penta vaccinations from 4, 8 and 12 week intervals to 6, 10 and 14 week intervals, taking into account the future introduction of vaccines and the need to reduce on missed opportunities. Program Management and Coordination: Recommendation

Financing Maintain the MoH budget line for EPI (protected funds) [MoH] Strengthen resource mobilization efforts locally through: Exploring of external funding sources through proposal development for grants or credit Logistics, Vaccine Supply & Quality Expand storage capacity at national, regional and district level to accommodate all vaccines Urgently improve the over-sight role of the National EPI Logistics unit to properly manage vaccines in the country. Include EPI injection materials in the list of priority supplies for fast track clearance (MSD)

Wild Polio Virus type 1 in Kalemie DRC: Outbreak and response in Tanzania Two regions Kigoma and Rukwa border or have interaction with Kalemie District in DRC Intensified active search done in both regions: 4 AFP cases picked and sent to the lab. 1 st Round vaccination campaign done in all districts bordering Kalemie Planned activities according to ACPE: WHO 2 nd round of vaccination campaign using house to house approach will be conducted from 9 th to 12 th October 2010 using monovalent OPV 1 Continue with active search of cases Intensifying routine immunization in other regions Case detected 20 June 2010

GAVI support to introduce the new vaccines: Got conditional approval for introduction Pneumococcal and Rotavirus Required to submit the plans to expand the cold chain storage in the country. Merck Co. support to introduce HPV: 2,000,000 doses Challenges Operational costs for introduction of new vaccines Increase volume for logistics Human resources at facility level Introduction of new vaccines

Take in account recommendation from WHO Technical Advisory Group to prevent measles outbreaks Due to high number of cumulative un vaccinated children since last measles mass campaign in 2008 The country is required to conduct mass measles campaign in 2011 Target age group 9 to 59 months Measles campaign: 2 nd dose

Work on the EPI Review recommendations Urgent follow up to expand the cold chain capacity Resource mobilization for introduction of new vaccines in 2011: HPV and Pneumococcal Resource mobilization for measles campaign in Way forward

Asante sana Thank you